Prostate Cancer

The Pharmacy Times® Prostate Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancer that occurs in the prostate.

Latest News

A Drug box of Xtandi containing Enzalutamide for treatment of prostate cancer on a table and in the background different medical books. Image Credit: omar | stock.adobe.com
Enzalutamide Plus Leuprolide Extends Survival in High-Risk Non-Metastatic Prostate Cancer

July 18th 2025

Enzalutamide combined with leuprolide significantly enhances survival in high-risk non-metastatic prostate cancer, marking a breakthrough in treatment strategies.

Conceptual image for prostate cancer treatment, 3D illustration showing destruction of a tumor inside prostate gland - Image credit: Dr_Microbe | stock.adobe.com
TRE-5151 Receives FDA Fast Track Designation in Combination With Radiation Therapy for Prostate Cancer

July 14th 2025

Darolutamide Approved by FDA for Metastatic Castration-Sensitive Prostate Cancer
Darolutamide Approved by FDA for Metastatic Castration-Sensitive Prostate Cancer

June 3rd 2025

Prostate disease and treatment. Male reproductive system anatomical model in doctors hands close-up during consultation of male patient with suspected bacterial prostatitis - Image credit: Peakstock | stock.adobe.com
Anti-Diabetic Drug Could Offer New Treatment for Prostate Cancer

May 20th 2025

Prostate cancer cells dividing | Image Credit: © PRB ARTS - stock.adobe.com
ASCO GU: ARANOTE and ARASENS Trials Reinforce Darolutamide in Metastatic Hormone-Sensitive Prostate Cancer

February 26th 2025

More News